IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

CUSIP: 45168K306

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
48,636,323
Share change
+14,094,752
Total reported value
$72,958,469
Put/Call ratio
294%
Price per share
$1.50
Number of holders
81
Value change
+$20,316,013
Number of buys
55
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 45168K306?
CUSIP 45168K306 identifies IDRA - IDERA PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2016

As of 31 Dec 2016, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,636,323 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Broadfin Capital, LLC, BlackRock Fund Advisors, NATIXIS, JPMORGAN CHASE & CO, BlackRock Institutional Trust Company, N.A., FMR LLC, RA CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.